$ USD
¥ 人民币
$ USD
€ 欧元
English
简体中文
English
繁体中文
Sign In / Sign up
Home page
News
Tumor Information
Tumor Information
Tumor medication
Tumor medication
Drug data
Drug data
Tumor medication
Oncology
renal cell carcinoma
cell tumor
solid tumors
IDH1 mutation
non-small cell lung cancer
neurofibromatosis
liposarcoma
neurofibromatosis
Cachexia
bladder cancer
Common Medications
Common medications
Hematology
Hepatobiliary
chronic disease
Endocrinology
Rare disease drugs
Other medications
insomnia
depression
chronic cough
kidney transplant
Drug Classification
Brand Medicine Search
Brand Medicine Search
日本日医工株式会社
日本盐野义制药
日本杏林制药株式会社
日本株式会社
老挝卢修斯
hormone receptor positive
constipate
heart disease
constipate
depression
日本株式会社
日本田边三菱
英国FuturaMedical制药
日本盐野义制药
日本杏林制药株式会社
Medical Q&A
Medical Q&A
About Us
About Us
Menu
Home page
News
Tumor Information
Tumor Information
Tumor medication
Tumor medication
Drug data
Drug data
Tumor medication
Oncology
renal cell carcinoma
cell tumor
solid tumors
IDH1 mutation
non-small cell lung cancer
neurofibromatosis
liposarcoma
neurofibromatosis
Cachexia
bladder cancer
Common Medications
Common medications
Hematology
Hepatobiliary
chronic disease
Endocrinology
Rare disease drugs
Other medications
insomnia
depression
chronic cough
kidney transplant
Drug Classification
Brand Medicine Search
Brand Medicine Search
日本日医工株式会社
日本盐野义制药
日本杏林制药株式会社
日本株式会社
老挝卢修斯
hormone receptor positive
constipate
heart disease
constipate
depression
日本株式会社
日本田边三菱
英国FuturaMedical制药
日本盐野义制药
日本杏林制药株式会社
Medical Q&A
Medical Q&A
About Us
About Us
Home
News
News
Medical Halo Global Pharmaceutical News_Targeted Drugs_New Anti-Cancer Drugs_Overseas Medical Information_【Medical Halo Global Pharmaceutical】
Lenvatinib (Lenvatinib) belongs to which generation of targeted drugs?
2026-02-01 22:25:32
Check Details
Is Lenvatinib on for 21 days and off for 7 days?
2026-02-01 22:25:32
Check Details
The mechanism of action of lenvatinib (lenvatinib) in the treatment of cancer
2026-02-01 22:25:32
Check Details
How long should I take Lenvatinib for?
2026-02-01 22:25:32
Check Details
Are palbociclib and palbociclib the same drug, or are there any differences between them?
2026-02-01 22:25:32
Check Details
Palbociclib/palbociclib is developed and produced by which company?
2026-02-01 22:25:32
Check Details
What is the market price of palbociclib/palbociclib in China?
2026-02-01 22:25:32
Check Details
Palbociclib/Palbociclib Latest News: Zanidatamab in combination with palbociclib and fulvestrant
2026-02-01 22:25:32
Check Details
Axitinib targeted drug instructions
2026-02-01 22:25:32
Check Details
Axitinib medical insurance price in 2024
2026-02-01 22:25:32
Check Details
How much does a box of axitinib cost?
2026-02-01 22:25:32
Check Details
Axitinib side effects and treatments
2026-02-01 22:25:32
Check Details
1
2
...
753
754
755
756
757
758
759
...
10223
10224
Category
Oncology
Hepatobiliary
dermatology
Endocrinology
Hematology
Andrology
Gynecology
Nephrology
Urology
Department of Infectious Diseases
Gastroenterology
Respiratory department
Neurology
Cardiology and Brain Department
ophthalmology
Psychiatry
Immunology Department
orthopedics
Burn Department
相关知识
1
Tivozanib: A Next-Generation Highly Selective VEGFR-Targeted Therapy Explained
2
Capmatinib Clinical Guide: Drug Comparisons, Treatment Strategies, and Combination Therapy Prospects
3
Avatrombopag Complete Guide: Efficacy, Indications, and TPO-RA Drug Comparisons
4
Pralsetinib Clinical Guide: Discontinuation Principles, Drug Comparisons, and Treatment Strategies
5
Venetoclax Clinical Guide: Mechanism, Indications, and Originator vs. Generic Comparison
6
Dabrafenib Clinical Guide: Indications, Combination Strategies, and BRAF Inhibitor Comparisons
7
Elagolix Side Effects and Safety Guide
8
Hetrombopag vs. Avatrombopag: Key Differences Between Two Oral TPO-RAs and Safety Considerations
9
Lytenava: The First FDA-Approved Ophthalmic Bevacizumab Formulation
10
FDA Approves Lytenava: First Ophthalmic Bevacizumab for Wet AMD
11
Simtriyo (Centanafadine): World's First NDSRI ADHD Drug Approved by FDA
12
Lipfendra (Enlicitide): The World's First Oral PCSK9 Inhibitor Approved by FDA